Tag: Vaccines

COVID-19 vaccine acceptance twice as high if Tdap or influenza vaccinations also received

In Michigan, those with sickle cell disease have half the coverage rate of people without sickle cell disease

Lymph node-targeting Amphiphile vaccine is safe; correlation seen for efficacy with T-cell response

Changes include recommendation for all adults to receive dose of new COVID-19 vaccine and RSV vaccination

Findings seen for adults aged 65 years and older and for those aged 18 years and older with end-stage renal disease

Reduced heart rate variability observed in patients with postvaccination postural orthostatic tachycardia syndrome

Vaccine effectiveness wanes after one dose but remains relatively unchanged over four years after two doses

Estimated effectiveness did not wane during delta period but did decline against the omicron variant after the first dose

Second study shows that 42.2 and 18.3 percent of individuals aged 18 years and older reported receiving flu, updated COVID-19 shots

Vaccine efficacy was 68.4 percent against RSV-associated acute respiratory disease; offers protection against subtypes A and B